New insights into cardiac stem cells could lead to heart …
By Dr. Matthew Watson
University of Arizona researchers Churko and colleagues describe new findings of gene expression patterns in cardiac stem cells, which could be used to create heart regeneration therapies.
Heart disease affects millions of people each year and has the potential to impair heart function by damaging heart muscle. Although many preventative therapies are available, once damage has occurred to the cells of the heart, there are not many treatment options available. The heart has a limited capacity to heal itself, but one option that could result from new research into stem cell therapies is regenerative therapy, leading to cardiac regeneration. However, the processes involved in stem cell differentiation into various heart muscle tissues are not well understood.
In a new study published in Nature Communications, University of Arizona researchers Churko and colleagues investigate the gene expression patterns that are responsible for the differentiation of heart cells. This will clarify how heart cells develop and respond to drugs or other factors.
The researchers found that heart muscle cells vary in gene expression as they mature, between days 14 and 45. Younger cells have gene expression profiles more like those of cells of the heart atrium, whereas more mature cells have gene expression profiles more like those of the heart ventricle. Churko and colleagues also identified one gene, NR2F2, that, when overexpressed blunted expression of the specific genes that are expressed within muscle cells and heart cells, and led to increased expression of the genes associated with pluripotent stem cells and neuronal cells.
Churko and colleagues findings will help other researchers working on heart stem cells and regenerative therapy. By understanding the genetic expression patterns that lead to or characterize the differentiation of stem cells into heart muscle cells, researchers will be able to guide pluripotent stem cells into becoming cardiac cells. Ultimately, this will lead to better treatment for patients with heart disease and a damaged heart.
Written by C.I. Villamil
Reference: Churko et al. 2018. Defining human cardiac transcription factor hierarchies using integrated single-cell heterogeneity analysis. Nature communications 9:4906.
Read the original post:
New insights into cardiac stem cells could lead to heart ...
- MarketsandMarkets 4th Annual Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress - Galus Australis - December 9th, 2019
- AgeX Therapeutics Issues Year-End Letter to Shareholders - BioSpace - December 9th, 2019
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market share, size, opportunities, producers, growth factors by 2026 - Health Opinion - December 9th, 2019
- The Ins and Outs of Organ Donation - The Wire - December 9th, 2019
- Meditation increases blood flow in the heart, PET scans show - Health Imaging - December 8th, 2019
- With another $26M, Japan's Heartseed aims to advance iPSC-derived regenerative medicine for heart failure - BioWorld Online - December 8th, 2019
- CALQUENCE Significantly Prolonged the Time Patients Lived Without Disease Progression or Death in Previously Untreated Chronic Lymphocytic Leukemia -... - December 8th, 2019
- PHATED to be: Yale researchers give shape to big data - Yale News - December 6th, 2019
- Spinning Disk Confocal Microscope Market Growth Fueled by Reviving Techniques to Treat Heart Failure with Cardiac Regenerative Medicine - MENAFN.COM - December 6th, 2019
- Stem Cell Therapy Market Robust pace of Industry during 2017-2025 - News Description - December 6th, 2019
- Year in Review: Respiratory Infection - MedPage Today - December 6th, 2019
- MarketsandMarkets - 4th Annual Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress - Hitz Dairies - December 6th, 2019
- Global Synthetic Stem Cells Market :Industry Analysis and Forecast (2018-2026) - The Market Expedition - December 3rd, 2019
- Professor Recognized For Cardiac Regeneration Research - WPI News - December 3rd, 2019
- Stem cells may trigger immune repair to mend hearts - BioNews - December 2nd, 2019
- Stem cells do help restore heart function but in a different way - News-Medical.net - November 29th, 2019
- Can intermittent fasting help you live long? - Times of India - November 29th, 2019
- Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca - GlobeNewswire - November 29th, 2019
- Toddler Bravely Cheats Death After He Survived Rare Cancer And Its Treatment - The Digital Weekly - November 29th, 2019
- South Carolina toddler survives rare cancer and the risky procedure used to treat it - USA TODAY - November 28th, 2019
- Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZene - PharmiWeb.com - November 28th, 2019
- Stem cells don't repair injured hearts, but inflammation might, study finds - FierceBiotech - November 28th, 2019
- Stem Cell Therapy May Improve Heart Health In New Ways - TheHealthMania - November 28th, 2019
- 'My daughter's death took me to the darkest place, but I've learned it's possible to come back' - Telegraph.co.uk - November 28th, 2019
- Stem Cell Assay Market Demand with Leading Key Players and New Investment Opportunities Emerge To Augment Segments in Sector By 2025 - The Denton... - November 28th, 2019
- Activation of the Immune System Underlies Cardiac Cell Therapies - The Scientist - November 27th, 2019
- Cell Separation Technology Market Size Projected to Rise Lucratively During 2019 2027 - News Description - November 27th, 2019
- Merck's KEYTRUDA (pembrolizumab) Now Approved in China for First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) in... - November 26th, 2019
- Trump is blocking vital biomedical research - CNN - November 26th, 2019
- Stem Cell Therapy Market Segmentation, Assessment and Growth Opportunities by Forecast 2025 - Tech Admirers - November 26th, 2019
- Stem Cells For Heart Health: What The Current Research ... - November 25th, 2019
- Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx(TM) 100 | INN -... - November 25th, 2019
- Biobots are hybrid machines that have muscles and nerves - DesignNews - November 23rd, 2019
- CALQUENCE Approved in the US for Adult Patients With Chronic Lymphocytic Leukemia - Business Wire - November 23rd, 2019
- Suspended animation induced in humans for the first time - CNET - November 22nd, 2019
- AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annual Meeting - P&T Community - November 22nd, 2019
- Cell Separation Technology Market Growth Forecast through 2019-2027 with Upcoming Trends and Market Opportunities - Montana Ledger - November 22nd, 2019
- CALQUENCE Approved in the US for Adult Patients With Chronic Lymphocytic Leukemia - BioSpace - November 22nd, 2019
- Cell Separation Technology Market is Expected To Elevate To a Stellar Value of US$ 2.7 Bn by 2027 - Downey Magazine - November 22nd, 2019
- Breaking News: Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx(TM) 100... - November 20th, 2019
- Stem Cell Therapy Market to Surge at a Robust Pace in Terms of Revenue Over 2025 - The Denton Chronicle - November 20th, 2019
- European Commission Approves Two New Regimens of Merck's KEYTRUDA (pembrolizumab) as First-Line Treatment for Metastatic or Unresectable Recurrent... - November 20th, 2019
- Validea's Top Five Healthcare Stocks Based On Motley Fool - 11/17/2019 - Nasdaq - November 18th, 2019
- Human heart cells behave differently in space - SellRegular - November 18th, 2019
- New cell therapy improves memory and stops seizures following TBI: Study - ANI News - November 17th, 2019
- Celgene Receives CHMP Positive Opinion for REVLIMID (lenalidomide) in Combination With Rituximab for the Treatment of Adult Patients With Previously... - November 15th, 2019
- The Heart of the Matter: Leveraging Advances in Cardiac Biology to Innovate Gene-Based Therapies for Heart Failure - Physician's Weekly - November 14th, 2019
- Human Heart Cells Transform in Space; Return to Normal on Earth: Study - The Weather Channel - November 14th, 2019
- Human Heart Cells Alter In Spaceflight But Return To Normal Quickly On Earth - Pragativadi - November 12th, 2019
- Financial Contrast: BioRestorative Therapies (OTCMKTS:BRTX) and Livongo Health (OTCMKTS:LVGO) - DFS Caller - November 12th, 2019
- Stem Cell Therapy Market Poised to Expand at a Robust Pace Over 2025 - Tech Admirers - November 11th, 2019
- Dystrogen Therapeutics Announces That Treatment With DEC Cells Improves Cardiac Function Cardiology2.0 - Cardiology2.0 - November 11th, 2019
- Reviewing US Stem Cell (OTCMKTS:USRM) and Auxly Cannabis Group (OTCMKTS:CBWTF) - Riverton Roll - November 11th, 2019
- Going into Space Changes the Human Heart Cells, but What Happens When They Get Back on Earth? - Henri Le Chat Noir - November 10th, 2019
- Dr Eilish McLoughlin honoured by SFI for Outstanding Contribution to STEM Communication - Dublin City University - November 9th, 2019
- Space travel affects heart cells, but only temporarily - BBC Focus Magazine - November 9th, 2019
- Teva and Celltrion Announce the Availability of TRUXIMA (rituximab-abbs) Injection, the First Biosimilar to Rituxan (rituximab) in the United States -... - November 8th, 2019
- Takeda to Highlight Expanded Portfolio of Products Across Oncology and Hematology at 61st American Society of Hematology (ASH) Annual Meeting -... - November 8th, 2019
- bluebird bio to Present New Data from Gene and Cell Therapy Programs at 61st American Society of Hematology Annual Meeting and Exposition - Financial... - November 6th, 2019
- Reviewing Capricor Therapeutics Inc. (CAPR)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - FinanceMercury - November 6th, 2019
- Dystrogen Therapeutics Announces That Treatment With Dystrophin Expressing Chimeric (DEC) Cells Improves Cardiac Function in Preclinical Duchenne's... - November 5th, 2019
- Future Outlook: Autologous Stem Cell Based Therapies Market Prediction and Analysis Offered By New Study 2019 2025: Leading Key Players: JCR... - November 5th, 2019
- Head-To-Head Analysis: BioRestorative Therapies (OTCMKTS:BRTX) versus Livongo Health (OTCMKTS:LVGO) - Casper Courier - November 5th, 2019
- Latest Released Report on Autologous Stem Cell Based Therapies Market to Witness the Highest Growth Globally in Coming Years: Osiris... - November 3rd, 2019
- InGeneron Announces Publication of Preclinical Results for its Cell Therapy in Chronic Ischemic Heart Failure - Business Wire - November 1st, 2019
- The Stars in Our Brains - Duke Department of Neurology - October 30th, 2019
- Global Cell Based Assay & High Content Screening Markets, 2020-2024 | Forecast by Application with Executive & Consultant Guides -... - October 30th, 2019
- Michael Schumacher: Has the racing champ recovered? Stem Cell Therapy doctor unknowingly confirmed Schumi's procedure? - EconoTimes - October 28th, 2019
- Regenerative Medicine Market Industry Outlook, Growth Prospects and Key Opportunities - Health News Office - October 25th, 2019
- Plant of the week: Plant thought to boost milk production now used for skin eruptions - Cyprus Mail - October 25th, 2019
- BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program - Yahoo Finance - October 23rd, 2019
- Bayer Announces Recipients of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards at CHEST Annual Meeting 2019 - PRNewswire - October 22nd, 2019
- Hemostemix Announces Positive Results and Conclusions Reported in Phase II CLI Trial Abstract - Yahoo Finance - October 22nd, 2019
- Hemostemix Announces Positive Results and Conclusions Reported in Phase II CLI Trial Abstract - GlobeNewswire - October 21st, 2019
- Best Growth Report On Autologous Stem Cell Based Therapies Market Survey 2019 Industry Outlines, Future Trends, Forecasts And Regional Segmented... - October 21st, 2019
- Bayer Announces Recipients of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards at CHEST Annual Meeting 2019 - BioSpace - October 21st, 2019
- Drug Treats Inflammation Related to Genetic Heart Disease - Technology Networks - October 18th, 2019
- Analysis on Worldwide Autologous Stem Cell Based Therapies Market Inclinations Exhibit Growing Demand During The Period Until 2025 - Wheel Chronicle - October 18th, 2019
- Sphingosine 1-phosphate: Lipid signaling in pathology and therapy - Science Magazine - October 18th, 2019
- Research Roundup: Genomic Dark Matter Mutation and More - BioSpace - October 18th, 2019
